RxSight Inc. (RXST) said it expects revenue for the fourth quarter 2024 to be
about $40.2 million, representing growth of approximately 41% from the prior year period.
RxSight anticipates full-year 2025 revenue in the range of $185.0 million to
$197.0 million, reflecting growth of approximately 32% to 41% over 2024.
The company currently estimates the full-year 2025 gross profit margin to be in the
71% to 73% range. In addition, the company expects full-year 2025 operating
expenses in the range of $165.0 million to $170.0 million, including non-cash
stock-based compensation expense guidance in the range of $22.0 million to
$25.0 million.
For comments and feedback: editorial@rttnews.com